<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03390000_1</Organism_ID>
  <Organism>Bovine</Organism>
  <Organism_Latin>Bos taurus</Organism_Latin>
  <UniProt_ID>P29473</UniProt_ID>
  <Seq_Length>1205</Seq_Length>
  <Molecule_Weight>133287</Molecule_Weight>
  <Function_Summary>Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets.</Function_Summary>
  <Catalytic_Mechanism>L-arginine + n NADPH + n H(+) + m O(2) = citrulline + nitric oxide + n NADP(+).</Catalytic_Mechanism>
  <Pfam_ID>PF00667:FAD_binding_1@@PF00258:Flavodoxin_1@@PF00175:NAD_binding_1@@PF02898:NO_synthase</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Constitutive NOS</Alias>
      <Alias>NOSIII</Alias>
      <Alias>Enos</Alias>
      <Alias>Endothelial nitric oxide synthase</Alias>
      <Alias>Endothelial NOS</Alias>
      <Alias>EC-NOS</Alias>
      <Alias>NOS type III</Alias>
      <Alias>CNOS</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: L-arginine + n NADPH + n H+ + m O2 = citrulline + nitric oxide + n NADP+.</Detail>
      <Keyword>Nitric-oxide synthase activity</Keyword>
      <Ontology_ID>GO:0004517</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.</Detail>
      <Keyword>Heme binding</Keyword>
      <Ontology_ID>GO:0020037</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.</Detail>
      <Keyword>Flavin adenine dinucleotide binding</Keyword>
      <Ontology_ID>GO:0050660</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calmodulin, a calcium-binding protein with many roles, both in the calcium-bound and calcium-free states.</Detail>
      <Keyword>Calmodulin binding</Keyword>
      <Ontology_ID>GO:0005516</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with FMN, flavin mononucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.</Detail>
      <Keyword>FMN binding</Keyword>
      <Ontology_ID>GO:0010181</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.</Detail>
      <Keyword>NADP binding</Keyword>
      <Ontology_ID>GO:0050661</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A process which directly inhibits any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Anti-apoptosis</Keyword>
      <Ontology_ID>GO:0006916</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.</Detail>
      <Keyword>Arginine catabolic process</Keyword>
      <Ontology_ID>GO:0006527</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water.</Detail>
      <Keyword>Nitric oxide biosynthetic process</Keyword>
      <Ontology_ID>GO:0006809</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.</Detail>
      <Keyword>Hemostasis</Keyword>
      <Ontology_ID>GO:0007599</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components.</Detail>
      <Keyword>Mitochondrion organization</Keyword>
      <Ontology_ID>GO:0007005</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of guanylate cyclase activity.</Detail>
      <Keyword>Positive regulation of guanylate cyclase activity</Keyword>
      <Ontology_ID>GO:0031284</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>143</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>635</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>83</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>1177</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>116</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>1179</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>497</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MGNLKSVGQEPGPPCGLGLGLGLGLCGKQGPASPAPEPSRAPAPATPHAPDHSPAPNSPTLTRPPEGPKFPRVKNWELGSITYDTLCAQSQQDGPCTPRCCLGSLVLPRKLQTRPSPGPPPAEQLLSQARDFINQYYSSIKRSGSQAHEERLQEVEAEVASTGTYHLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCSSAQEMFTYICNHIKYATNRGNLRSAITVFPQRAPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEAPELFVLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFSAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINLAVLHSFQLAKVTIVDHHAATVSFMKHLDNEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYILSPAFRYQPDPWKGSATKGAGITRKKTFKEVANAVKISASLMGTLMAKRVKATILYASETGRAQSYAQQLGRLFRKAFDPRVLCMDEYDVVSLEHEALVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSSPRPEQHKSYKIRFNSVSCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHFCAFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAKAAFQASCETFCVGEEAKAAAQDIFSPKRSWKRQRYRLSTQAEGLQLLPGLIHVHRRKMFQATVLSVENLQSSKSTRATILVRLDTAGQEGLQYQPGDHIGICPPNRPGLVEALLSRVEDPPPPTESVAVEQLEKGSPGGPPPSWVRDPRLPPCTLRQALTFFLDITSPPSPRLLRLLSTLAEEPSEQQELETLSQDPRRYEEWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPNAHPGEVHLTVAVLAYRTQDGLGPLHYGVCSTWLSQLKTGDPVPCFIRGAPSFRLPPDPYVPCILVGPGTGIAPFRGFWQERLHDIESKGLQPAPMTLVFGCRCSQLDHLYRDEVQDAQERGVFGRVLTAFSREPDSPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATSVLQTVQRILATEGDMELDEAGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERHLRGAVPWAFDPPGPDTPGP</Protein_Seq>
    <DNA_Seq>GGCACGAGGCCCCAGCGACATGGGCAACTTGAAGAGTGTGGGCCAGGAGCCCGGGCCCCCCTGCGGCCTGGGGCTGGGGCTGGGCCTCGGGCTATGCGGCAAGCAGGGCCCAGCCTCCCCGGCACCTGAGCCCAGCCGGGCCCCCGCACCCGCCACCCCGCACGCGCCAGACCACAGCCCAGCTCCCAACAGCCCCACGCTGACCCGGCCTCCGGAGGGGCCCAAGTTCCCTCGCGTGAAGAACTGGGAGCTGGGGAGCATCACCTACGACACTCTGTGCGCGCAGTCCCAACAGGACGGGCCCTGCACTCCCAGGTGCTGCCTGGGCTCCCTGGTGTTGCCCCGGAAACTGCAGACCCGGCCCTCCCCGGGACCTCCACCCGCTGAGCAGCTGCTGAGCCAGGCCAGGGACTTCATCAACCAGTACTACAGCTCCATCAAGAGGAGTGGCTCCCAGGCTCACGAGGAGCGGCTTCAGGAGGTGGAGGCCGAGGTGGCATCCACGGGCACCTACCACCTCCGAGAGAGCGAGCTGGTGTTCGGGGCCAAGCAGGCCTGGCGCAACGCACCCCGCTGCGTGGGCCGCATCCAGTGGGGGAAGCTGCAGGTGTTTGATGCCCGGGACTGCAGCTCAGCACAGGAGATGTTCACCTACATCTGCAACCACATCAAGTACGCCACCAACCGCGGCAACCTTCGCTCGGCCATCACAGTGTTCCCGCAGCGCGCCCCGGGCCGCGGAGACTTCCGGATCTGGAACAGCCAGCTGGTGCGCTACGCAGGCTACAGACAGCAGGATGGCTCTGTGCGTGGGGACCCAGCCAATGTGGAGATCACGGAGCTCTGCATCCAGCACGGCTGGACCCCCGGAAACGGCCGCTTCGACGTGCTGCCCCTGCTGCTCCAGGCCCCAGACGAGGCTCCAGAGCTCTTTGTTCTGCCCCCCGAGCTGGTCCTTGAAGTGCCCCTGGAGCACCCCACACTGGAGTGGTTCGCGGCCCTGGGCCTGCGATGGTATGCCCTCCCGGCCGTGTCCAACATGCTGCTGGAAATCGGGGGTCTGGAGTTCTCCGCGGCCCCCTTCAGCGGCTGGTACATGAGCACGGAGATTGGCACGCGGAACCTGTGTGACCCTCACCGCTACAATATCCTGGAGGATGTGGCCGTCTGCATGGACCTCGACACGCGGACCACCTCGTCCCTGTGGAAGGACAAGGCGGCCGTGGAGATCAACCTGGCTGTGCTGCACAGCTTTCAGCTCGCCAAGGTGACCATCGTGGACCACCACGCCGCCACGGTGTCCTTCATGAAGCACCTGGACAACGAGCAGAAGGCCAGGGGGGGCTGCCCCGCCGACTGGGCCTGGATCGTGCCCCCCATCTCAGGCAGCCTCACGCCCGTCTTCCACCAGGAGATGGTCAACTACATCCTGTCCCCTGCCTTCCGCTACCAGCCAGACCCCTGGAAAGGGAGCGCGACCAAGGGCGCAGGCATCACCAGGAAGAAGACCTTTAAGGAAGTGGCCAACGCGGTGAAGATCTCTGCCTCACTCATGGGCACCCTGATGGCCAAGCGAGTGAAAGCAACCATCCTGTACGCCTCTGAGACCGGCCGGGCCCAGAGCTACGCTCAGCAGCTGGGGAGGCTCTTCCGGAAGGCCTTCGATCCCCGGGTCCTGTGCATGGATGAGTATGACGTGGTGTCCCTGGAGCACGAGGCGCTGGTACTGGTGGTGACCAGCACCTTTGGGAATGGCGATCCCCCGGAGAATGGAGAGAGTTTTGCAGCTGCCCTGATGGAGATGTCGGGGCCCTACAACAGCTCCCCGCGGCCGGAACAGCACAAGAGTTACAAGATCCGCTTCAACAGCGTCTCCTGCTCAGACCCGCTGGTGTCCTCCTGGCGGCGGAAGAGAAAGGAGTCCAGCAACACAGACAGTGCGGGGGCCCTGGGGACCCTCAGGTTCTGTGTGTTCGGACTGGGCTCCCGGGCATACCCCCACTTCTGCGCCTTCGCGCGAGCGGTGGACACCCGGCTGGAAGAGCTTGGAGGGGAGCGGCTGCTGCAGCTGGGCCAGGGCGATGAGCTCTGCGGCCAGGAAGAGGCCTTCCGTGGTTGGGCAAAGGCGGCCTTCCAGGCCTCCTGTGAGACCTTCTGCGTTGGGGAGGAGGCCAAGGCCGCCGCCCAGGACATCTTCAGCCCCAAACGGAGCTGGAAACGCCAGAGGTACCGGCTGAGCACCCAGGCCGAGGGCCTCCAGCTGCTGCCAGGCCTGATCCACGTGCACAGACGGAAGATGTTTCAGGCCACAGTCCTCTCGGTGGAAAATCTGCAAAGCAGCAAGTCCACCCGGGCCACCATCCTGGTGCGCCTGGACACTGCAGGCCAGGAGGGGCTGCAGTACCAGCCGGGGGACCACATAGGCATCTGCCCGCCCAACCGGCCGGGCCTGGTGGAGGCGCTGCTGAGCCGCGTGGAGGACCCGCCACCGCCCACCGAGTCTGTGGCTGTGGAGCAGCTGGAGAAAGGCAGCCCAGGCGGCCCTCCTCCCAGCTGGGTGCGGGACCCACGGCTGCCCCCGTGCACGCTGCGCCAGGCTCTCACCTTCTTCCTGGACATCACCTCCCCACCCAGCCCCCGGCTTCTCCGACTGCTCAGCACCCTGGCCGAAGAACCCAGCGAGCAGCAGGAGCTTGAGACCCTCAGTCAGGACCCCCGGCGCTACGAGGAGTGGAAGTGGTTCCGCTGCCCCACGCTGCTGGAGGTGCTGGAGCAGTTCCCGTCCGTGGCGCTGCCCGCCCCGCTGCTCCTCACCCAGCTGCCCCTGCTGCAGCCCCGGTACTACTCTGTCAGCTCGGCCCCCAACGCCCACCCCGGAGAGGTCCACCTCACAGTGGCCGTGCTGGCGTACAGGACCCAAGATGGGCTGGGCCCCCTACACTACGGGGTCTGCTCCACATGGCTGAGCCAGCTCAAGACTGGAGACCCCGTGCCCTGCTTCATCAGGGGGGCTCCCTCCTTCCGGCTGCCGCCTGACCCCTACGTGCCCTGCATCCTCGTGGGCCCTGGCACTGGCATCGCCCCCTTCCGGGGATTTTGGCAGGAGAGGCTGCATGACATTGAGAGCAAAGGGCTGCAGCCCGCCCCCATGACCCTGGTGTTCGGCTGCCGCTGCTCCCAACTCGACCATCTCTACCGCGACGAGGTGCAGGACGCCCAGGAGCGCGGGGTGTTTGGCCGCGTCCTCACCGCCTTCTCCCGGGAACCTGACAGCCCCAAGACCTACGTACAGGACATCCTGAGAACCGAGCTGGCTGCCGAGGTGCACCGCGTGCTGTGCCTCGAGCGGGGCCACATGTTTGTCTGCGGCGATGTCACTATGGCAACCAGCGTCCTGCAGACGGTGCAGCGCATCTTGGCGACAGAGGGCGACATGGAGCTGGACGAGGCGGGCGACGTCATCGGCGTGCTGCGGGATCAGCAACGCTATCACGAGGACATTTTCGGCCTCACGCTGCGCACCCAGGAGGTGACAAGCCGTATACGTACCCAGAGCTTTTCCCTGCAGGAGCGGCATCTGCGGGGCGCGGTGCCCTGGGCCTTCGACCCGCCCGGCCCAGACACCCCCGGCCCCTGAGACCCCTCTTGCTTCCCACTGCAGTTCCCGGAGAGAGGGGCTGTCATTCCACTATGGCTCTACCGCTGTCCTGTTGGCCTTTACCGGGACCGGCTCGTGCC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Endothelial cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Caveola</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi apparatus</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>NOS3</Gene_Name>
    <Genbank_ACCN>M99057</Genbank_ACCN>
    <Protein_ACCN>AAA30667</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/287024</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Bovine eNOS heme domain complexed with (4S)-N-{4-Amino-5-[(2-aminoethyl)-hydroxyamino]-pentyl}-N'-nitroguanidine</PDB_Title>
      <PDB_ID>2HX2</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HX2</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(4S)-N-{4-AMINO-5-[(2-AMINOETHYL)(HYDROXYAMINO]- PENTYL}-N'-NITROGUANIDINE $ ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>Structure-Based Design and Synthesis of N(omega)-Nitro-l-Arginine-Containing Peptidomimetics as Selective Inhibitors of Neuronal Nitric Oxide Synthase. Displacement of the Heme Structural Water.</PubMed_Title>
      <Author>Seo J, et al.</Author>
      <Journal>J Med Chem.2007 May 3;50(9):2089-99. Epub  2007 Apr 11.</Journal>
      <PubMed_ID>17425297</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of endothelial NOS heme domain in complex with a inhibitor (+-)-N1-{cis-4'-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3'-yl}-N2-(4'-chlorobenzyl)ethane-1,2-diamine</PDB_Title>
      <PDB_ID>3DQS</PDB_ID>
      <Resolution>2.03</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DQS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2- YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE- 1,2-DIAMINE  $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $  ACETATE ION</Ligand_Name>
      <PubMed_Title>Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.</PubMed_Title>
      <Author>Igarashi J, et al.</Author>
      <Journal>J Med Chem.2009 Apr 9;52(7):2060-6.</Journal>
      <PubMed_ID>19296678</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of endothelial NOS heme domain in complex with a inhibitor (+-)-N1-{trans-4'-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3'-yl}-N2-(3'-chlorobenzyl)ethane-1,2-diamine</PDB_Title>
      <PDB_ID>3DQT</PDB_ID>
      <Resolution>2.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DQT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2- yl)methyl]pyrrolidin-3-yl}-N'-(3
-chlorobenzyl)ethane- 1,2-diamine $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $  ACETATE ION</Ligand_Name>
      <PubMed_Title>Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.</PubMed_Title>
      <Author>Igarashi J, et al.</Author>
      <Journal>J Med Chem.2009 Apr 9;52(7):2060-6.</Journal>
      <PubMed_ID>19296678</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial NOS heme domain with L-N(omega)-nitroarginine-2,4-L-diaminobutyric amide bound</PDB_Title>
      <PDB_ID>1P6L</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P6L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ L-N(OMEGA)-NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.</PubMed_Title>
      <Author>Flinspach ML, et al.</Author>
      <Journal>Nat Struct Mol Biol.2004 Jan;11(1):54-9. Epub  2003 Dec 29.</Journal>
      <PubMed_ID>14718923</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, ETHYL-ISOSELENOUREA COMPLEX</PDB_Title>
      <PDB_ID>9NSE</PDB_ID>
      <Resolution>2.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=9NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ SE-ETHYL-ISOSELENOUREA</Ligand_Name>
      <PubMed_Title>Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>J Inorg Biochem.2000 Aug 31;81(3):133-9.</Journal>
      <PubMed_ID>11051558</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 4-AMINO-6-PHENYL-TETRAHYDROPTERIDINE</PDB_Title>
      <PDB_ID>1DMK</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DMK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ 2,4-DIAMINO-6-PHENYL-5,6,7,8,-TETRAHYDROPTERIDINE $ PROTOPORPHYRIN IX CONTAINING FE $ ETHYLISOTHIOUREA $ ZINC ION</Ligand_Name>
      <PubMed_Title>Structural basis for pterin antagonism in nitric-oxide synthase. Development of novel 4-oxo-pteridine antagonists of (6R)-5,6,7,8-tetrahydrobiopterin</PubMed_Title>
      <Author>Kotsonis P, et al.</Author>
      <Journal>J Biol Chem.2001 Dec 28;276(52):49133-41. Epub  2001 Oct 5.</Journal>
      <PubMed_ID>11590164</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-NIO (H4B FREE)</PDB_Title>
      <PDB_ID>1ED6</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ED6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ N5-IMINOETHYL-L-ORNITHINE $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2001 May 8;40(18):5399-406.</Journal>
      <PubMed_ID>11331003</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial nitric oxide synthase N368D mutant heme domain dimer with L-N(omega)-nitroarginine-2,4-L-diaminobutyramide bound</PDB_Title>
      <PDB_ID>1Q2O</PDB_ID>
      <Resolution>1.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Q2O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ L-N(OMEGA)-NITROARGININE-2,4-L-DIAMINOBUTYRIC AMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ CACODYLATE ION</Ligand_Name>
      <PubMed_Title>Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.</PubMed_Title>
      <Author>Flinspach ML, et al.</Author>
      <Journal>Nat Struct Mol Biol.2004 Jan;11(1):54-9. Epub  2003 Dec 29.</Journal>
      <PubMed_ID>14718923</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-FREE)</PDB_Title>
      <PDB_ID>1FOO</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FOO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ARGININE $ ACETATE ION $ CACODYLATE ION $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ GLYCEROL $ NITRIC OXIDE</Ligand_Name>
      <PubMed_Title>Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2001 May 8;40(18):5399-406.</Journal>
      <PubMed_ID>11331003</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 5,6-CYCLIC-TETRAHYDROPTERIDINE</PDB_Title>
      <PDB_ID>1DMJ</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DMJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ 7-AMINO-3,3A,4,5-TETRAHYDRO-8H-2-OXA-5,6,8,9B- TETRAAZA-CYCLOPENTA[A]NAPHTHALENE
-1,9-DIONE $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ ETHYLISOTHIOUREA $ ZINC ION</Ligand_Name>
      <PubMed_Title>Structural basis for pterin antagonism in nitric-oxide synthase. Development of novel 4-oxo-pteridine antagonists of (6R)-5,6,7,8-tetrahydrobiopterin</PubMed_Title>
      <Author>Kotsonis P, et al.</Author>
      <Journal>J Biol Chem.2001 Dec 28;276(52):49133-41. Epub  2001 Oct 5.</Journal>
      <PubMed_ID>11590164</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial NOS heme domain with D-lysine-D-nitroarginine amide bound</PDB_Title>
      <PDB_ID>1RS8</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RS8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ L-LYSYL-N~5~-[(Z)-(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]- L-ORNITHINAMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ CACODYLATE ION</Ligand_Name>
      <PubMed_Title>Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.</PubMed_Title>
      <Author>Flinspach M, et al.</Author>
      <Journal>Biochemistry.2004 May 11;43(18):5181-7.</Journal>
      <PubMed_ID>15122883</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, L-ARG COMPLEX</PDB_Title>
      <PDB_ID>4NSE</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ ARGININE</Ligand_Name>
      <PubMed_Title>Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Cell.1998 Dec 23;95(7):939-50.</Journal>
      <PubMed_ID>9875848</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>REDUCED BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG(H4B-FREE)</PDB_Title>
      <PDB_ID>1FOL</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FOL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ARGININE $ ACETATE ION $ CACODYLATE ION $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2001 May 8;40(18):5399-406.</Journal>
      <PubMed_ID>11331003</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, ADMA COMPLEX</PDB_Title>
      <PDB_ID>7NSE</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=7NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ NG,NG-DIMETHYL-L-ARGININE</Ligand_Name>
      <PubMed_Title>Crystal Structures of the Heme Domain of Bovine Endothelial Nitric Oxide Synthase Complexed with Arginine Analogues</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE (H4B FREE)</PDB_Title>
      <PDB_ID>1I83</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1I83</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ N1,N14-BIS((S-METHYL)ISOTHIOUREIDO)TETRADECANE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>J Biol Chem.2001 Jul 13;276(28):26486-91. Epub  2001 Apr 30.</Journal>
      <PubMed_ID>11331290</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,2,4-TRIAZOLE-CARBOXAMIDINE (H4B BOUND)</PDB_Title>
      <PDB_ID>1DM8</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DM8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ GLYCEROL $ 5,6,7,8-TETRAHYDROBIOPTERIN $ PROTOPORPHYRIN IX CONTAINING FE $ 1,2,4-TRIAZOLE-CARBOXAMIDINE $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal Structures of Bovine Endothelial Nitric Oxide Synthase Heme Domain Complexed With Various Inhibitors</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 7-NITROINDAZOLE-2-CARBOXAMIDINE (H4B PRESENT)</PDB_Title>
      <PDB_ID>1FOJ</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FOJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>7-NITROINDAZOLE-2-CARBOXAMIDINE $ 7-NITROINDAZOLE $ ACETATE ION $ CACODYLATE ION $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH N-(4-CHLOROPHENYL)-N'-HYDROXYGUANIDINE (H4B FREE)</PDB_Title>
      <PDB_ID>1DM6</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DM6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $N-(CHLOROPHENYL)-N'-HYDROXYGUANIDINE $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH IPITU (H4B FREE)</PDB_Title>
      <PDB_ID>1ED4</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ED4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ S-ISOPROPYL-ISOTHIOUREA $ ZINC ION</Ligand_Name>
      <PubMed_Title>Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>J Inorg Biochem.2000 Aug 31;81(3):133-9.</Journal>
      <PubMed_ID>11051558</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine eNOS N368D single mutant with L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide Bound</PDB_Title>
      <PDB_ID>1ZZS</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZZS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Exploring the Binding Conformations of Bulkier Dipeptide Amide Inhibitors in Constitutive Nitric Oxide Synthases.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2005 Nov 22;44(46):15222-9.</Journal>
      <PubMed_ID>16285725</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial NOS heme domain with (4S)-N-(4-amino-5-[aminoethyl]aminopentyl)-N'-nitroguanidine bound</PDB_Title>
      <PDB_ID>1P6M</PDB_ID>
      <Resolution>2.27</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P6M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ N-{(4S)-4-AMINO-5-[(2-AMINOETHYL)AMINO]PENTYL}- N'-NITROGUANIDINE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.</PubMed_Title>
      <Author>Flinspach ML, et al.</Author>
      <Journal>Nat Struct Mol Biol.2004 Jan;11(1):54-9. Epub  2003 Dec 29.</Journal>
      <PubMed_ID>14718923</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, HYDROXY-ARG COMPLEX</PDB_Title>
      <PDB_ID>5NSE</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=5NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ N-OMEGA-HYDROXY-L-ARGININE</Ligand_Name>
      <PubMed_Title>Crystal Structures of the Heme Domain of Bovine Endothelial Nitric Oxide Synthase Complexed with Arginine Analogues</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial NOS heme domain with D-phenylalanine-D-nitroarginine amide bound</PDB_Title>
      <PDB_ID>1RS9</PDB_ID>
      <Resolution>2.22</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RS9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ D-PHENYLALANYL-N~5~-[(2,2-DIHYDROXYHYDRAZINO)(IMINO)METHYL]- D-ORNITHINAMIDE  $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ CACODYLATE ION</Ligand_Name>
      <PubMed_Title>Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.</PubMed_Title>
      <Author>Flinspach M, et al.</Author>
      <Journal>Biochemistry.2004 May 11;43(18):5181-7.</Journal>
      <PubMed_ID>15122883</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,3-PBITU (H4B FREE)</PDB_Title>
      <PDB_ID>1D1Y</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D1Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-{2-[3-(2-CARBAMIMIDOYLSULFANYL-ETHYL)-PHENYL]- ETHYL}-ISOTHIOUREA $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $ 1,2-ETHANEDIOL $ GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>J Biol Chem.2001 Jul 13;276(28):26486-91. Epub  2001 Apr 30.</Journal>
      <PubMed_ID>11331290</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE</PDB_Title>
      <PDB_ID>1NSE</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ ETHYLISOTHIOUREA $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Cell.1998 Dec 23;95(7):939-50.</Journal>
      <PubMed_ID>9875848</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B PRESENT)</PDB_Title>
      <PDB_ID>1D0O</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D0O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>3-BROMO-7-NITROINDAZOLE $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $  GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 6S-H4B</PDB_Title>
      <PDB_ID>1DMI</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DMI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ 6S-5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ ETHYLISOTHIOUREA $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal Structures of Bovine Endothelial Nitric Oxide Synthase Heme Domain Complexed with the Pterin Analogues</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE SUBSTRATE COMPLEX</PDB_Title>
      <PDB_ID>2NSE</PDB_ID>
      <Resolution>2.34</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ARGININE $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Cell.1998 Dec 23;95(7):939-50.</Journal>
      <PubMed_ID>9875848</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENOS, H4B-FREE, SEITU COMPLEX</PDB_Title>
      <PDB_ID>3NSE</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ ARGININE $ ETHYLISOTHIOUREA</Ligand_Name>
      <PubMed_Title>Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Cell.1998 Dec 23;95(7):939-50.</Journal>
      <PubMed_ID>9875848</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, NNA COMPLEX</PDB_Title>
      <PDB_ID>8NSE</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=8NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-OMEGA-NITRO-L-ARGININE $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH HOMOARGININE (H4B FREE)</PDB_Title>
      <PDB_ID>1DM7</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DM7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ L-HOMOARGININE $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal Structures of Bovine Endothelial Nitric Oxide Synthase Heme Domain Complexed With Various Inhibitors</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE, H4B-FREE, CANAVANINE COMPLEX</PDB_Title>
      <PDB_ID>6NSE</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=6NSE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ L-CANAVANINE</Ligand_Name>
      <PubMed_Title>Crystal Structures of the Heme Domain of Bovine Endothelial Nitric Oxide Synthase Complexed with Arginine Analogues</PubMed_Title>
      <Author>Raman CS, et al.</Author>
    </PDB>
    <PDB>
      <PDB_Title>Structure of bovine eNOS heme domain (BH4-free) complexed with CO</PDB_Title>
      <PDB_ID>2G6O</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2G6O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ARGININE $ ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ CARBON MONOXIDE</Ligand_Name>
      <PubMed_Title>Structural studies of constitutive nitric oxide synthases with diatomic ligands bound.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>J Biol Inorg Chem.2006 Sep;11(6):753-68. Epub  2006 Jun 28.</Journal>
      <PubMed_ID>16804678</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1,4-PBITU (H4B BOUND)</PDB_Title>
      <PDB_ID>1D1X</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D1X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-{2-[4-(2-CARBAMIMIDOYLSULFANYL-ETHYL)-PHENYL]- ETHYL}-ISOTHIOUREA $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>J Biol Chem.2001 Jul 13;276(28):26486-91. Epub  2001 Apr 30.</Journal>
      <PubMed_ID>11331290</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH NNA(H4B FREE)</PDB_Title>
      <PDB_ID>1ED5</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ED5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLIC ACID $ GLYCEROL $ PROTOPORPHYRIN IX CONTAINING FE $ N-OMEGA-NITRO-L-ARGININE $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of bovine eNOS oxygenase domain with inhibitor AR-C95791</PDB_Title>
      <PDB_ID>3E7S</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3E7S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE $ HEME C $ ZINC ION</Ligand_Name>
      <PubMed_Title>Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.</PubMed_Title>
      <Author>Garcin ED, et al.</Author>
      <Journal>Nat Chem Biol.2008 Nov;4(11):700-7. Epub  2008 Oct 12.</Journal>
      <PubMed_ID>18849972</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 3-BROMO-7-NITROINDAZOLE (H4B FREE)</PDB_Title>
      <PDB_ID>1D0C</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D0C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>3-BROMO-7-NITROINDAZOLE $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $  GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>Biochemistry.2001 Nov 13;40(45):13448-55.</Journal>
      <PubMed_ID>11695891</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH S-ETHYL-N-PHENYL-ISOTHIOUREA (H4B BOUND)</PDB_Title>
      <PDB_ID>1D1V</PDB_ID>
      <Resolution>1.93</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D1V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-ETHYL-1-PHENYL-ISOTHIOUREA $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase.</PubMed_Title>
      <Author>Raman CS, et al.</Author>
      <Journal>J Biol Chem.2001 Jul 13;276(28):26486-91. Epub  2001 Apr 30.</Journal>
      <PubMed_ID>11331290</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 2-AMINOTHIAZOLINE (H4B BOUND)</PDB_Title>
      <PDB_ID>1D1W</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1D1W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-AMINOTHIAZOLINE $ ACETATE ION $ CACODYLATE ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL $ ZINC ION</Ligand_Name>
      <PubMed_Title>Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>J Inorg Biochem.2000 Aug 31;81(3):133-9.</Journal>
      <PubMed_ID>11051558</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine eNOS N368D/V106M double mutant with L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide Bound</PDB_Title>
      <PDB_ID>1ZZT</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZZT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>Exploring the Binding Conformations of Bulkier Dipeptide Amide Inhibitors in Constitutive Nitric Oxide Synthases.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2005 Nov 22;44(46):15222-9.</Journal>
      <PubMed_ID>16285725</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG AND NO(H4B-BOUND)</PDB_Title>
      <PDB_ID>1FOP</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FOP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ARGININE $ ACETATE ION $ CACODYLATE ION $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ GLYCEROL $ NITRIC OXIDE $ 5,6,7,8-TETRAHYDROBIOPTERIN</Ligand_Name>
      <PubMed_Title>Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2001 May 8;40(18):5399-406.</Journal>
      <PubMed_ID>11331003</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH 1400W(H4B-FREE)</PDB_Title>
      <PDB_ID>1FOI</PDB_ID>
      <Resolution>1.93</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FOI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE $ ACETATE ION $ CACODYLATE ION $ GLYCEROL $ ZINC ION $   PROTOPORPHYRIN IX CONTAINING FE</Ligand_Name>
      <PubMed_Title>Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.</PubMed_Title>
      <Author>Li H, et al.</Author>
      <Journal>Biochemistry.2001 May 8;40(18):5399-406.</Journal>
      <PubMed_ID>11331003</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Bovine endothelial NOS heme domain with L-N(omega)-nitroarginine-(4R)-amino-L-proline amide bound</PDB_Title>
      <PDB_ID>1P6N</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1P6N</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>ACETATE ION $ CACODYLATE ION $ L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE $ ZINC ION $ PROTOPORPHYRIN IX CONTAINING FE $ 5,6,7,8-TETRAHYDROBIOPTERIN $ GLYCEROL</Ligand_Name>
      <PubMed_Title>Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.</PubMed_Title>
      <Author>Flinspach ML, et al.</Author>
      <Journal>Nat Struct Mol Biol.2004 Jan;11(1):54-9. Epub  2003 Dec 29.</Journal>
      <PubMed_ID>14718923</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.deh.b.b.e.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1d0c</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Jobin CM, et al. Biochemistry. 2003,42(40):11716-11725.</Site_Reference>
      <Site_Type>Protein-induced</Site_Type>
      <PubMed_ID>14529282</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.14.13.39</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/13/39.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>